참고문헌
- Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162-173 https://doi.org/10.1016/S1474-4422(17)30470-2
- Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177-189 https://doi.org/10.1212/WNL.0000000000001729
- Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, et al. Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses. Ann Neurol 2016;79:206-216 https://doi.org/10.1002/ana.24554
- Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114 https://doi.org/10.1212/WNL.53.5.1107
- Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primers 2018;4:43
- Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112 https://doi.org/10.1016/S0140-6736(04)17551-X
- Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-477 https://doi.org/10.1084/jem.20050304
- Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012;11:535-544 https://doi.org/10.1016/S1474-4422(12)70133-3
- Traboulsee A, Simon JH, Stone L, Fisher E, Jones DE, Malhotra A, et al. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol 2016;37:394-401 https://doi.org/10.3174/ajnr.A4539
- Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, et al. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol 2021;20:653-670 https://doi.org/10.1016/S1474-4422(21)00095-8
- Vrenken H, Jenkinson M, Horsfield MA, Battaglini M, van Schijndel RA, Rostrup E, et al. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol 2013;260:2458-2471 https://doi.org/10.1007/s00415-012-6762-5
- Lee MY, Yong KP, Hyun JW, Kim SH, Lee SH, Kim HJ. Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder. Neurology 2020;95:e3124-e3128 https://doi.org/10.1212/WNL.0000000000010847
- Filippi M, Yousry T, Baratti C, Horsfield MA, Mammi S, Becker C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 1996;119(Pt 4):1349-1355 https://doi.org/10.1093/brain/119.4.1349
- Sahraian MA, Radue EW, Haller S, Kappos L. Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand 2010;122:1-8 https://doi.org/10.1111/j.1600-0404.2010.01367.x
- van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-754 https://doi.org/10.1002/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4
- Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 2019;142:1858-1875 https://doi.org/10.1093/brain/awz144
- Filippi M, Bruck W, Chard D, Fazekas F, Geurts JJG, Enzinger C, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 2019;18:198-210 https://doi.org/10.1016/S1474-4422(18)30451-4
- Calabrese M, Battaglini M, Giorgio A, Atzori M, Bernardi V, Mattisi I, et al. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology 2010;75:1234-1240 https://doi.org/10.1212/WNL.0b013e3181f5d4da
- Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011;76:418-424 https://doi.org/10.1212/WNL.0b013e31820a0cc4
- Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009;66:1144-1150 https://doi.org/10.1001/archneurol.2009.174
- Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, et al. The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis. Neurology 2018;90:e2107-e2118 https://doi.org/10.1212/WNL.0000000000005685
- Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63:390-396 https://doi.org/10.1001/archneur.63.3.390
- Kim SH, Kim W, Li XF, Jung IJ, Kim HJ. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology 2012;78:1179-1185 https://doi.org/10.1212/WNL.0b013e31824f8069
- Huh SY, Min JH, Kim W, Kim SH, Kim HJ, Kim BJ, et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler 2014;20:695-704 https://doi.org/10.1177/1352458513506953
- Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 2015;84:1165-1173 https://doi.org/10.1212/WNL.0000000000001367
- Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, et al. Tumefactive demyelination in MOG Ab-associated disease, multiple sclerosis, and AQP-4-IgG-positive neuromyelitis optica spectrum disorder. Neurology 2023;100:e1418-e1432
- Calabrese M, Oh MS, Favaretto A, Rinaldi F, Poretto V, Alessio S, et al. No MRI evidence of cortical lesions in neuromyelitis optica. Neurology 2012;79:1671-1676 https://doi.org/10.1212/WNL.0b013e31826e9a96
- Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, et al. Brain and cord imaging features in neuromyelitis optica spectrum disorders. Ann Neurol 2019;85:371-384 https://doi.org/10.1002/ana.25411
- Sinnecker T, Dorr J, Pfueller CF, Harms L, Ruprecht K, Jarius S, et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 2012;79:708-714 https://doi.org/10.1212/WNL.0b013e3182648bc8
- Saji E, Arakawa M, Yanagawa K, Toyoshima Y, Yokoseki A, Okamoto K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica. Ann Neurol 2013;73:65-76 https://doi.org/10.1002/ana.23721
- Tahara M, Ito R, Tanaka K, Tanaka M. Cortical and leptomeningeal involvement in three cases of neuromyelitis optica. Eur J Neurol 2012;19:e47-e48 https://doi.org/10.1111/j.1468-1331.2012.03667.x
- Kim W, Lee JE, Kim SH, Huh SY, Hyun JW, Jeong IH, et al. Cerebral cortex involvement in neuromyelitis optica spectrum disorder. J Clin Neurol 2016;12:188-193 https://doi.org/10.3988/jcn.2016.12.2.188
- Matthews L, Marasco R, Jenkinson M, Kuker W, Luppe S, Leite MI, et al. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 2013;80:1330-1337 https://doi.org/10.1212/WNL.0b013e3182887957
- Juryn'czyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, et al. Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease. J Neurol Neurosurg Psychiatry 2017;88:132-136 https://doi.org/10.1136/jnnp-2016-314005
- Sormani MP, Bruzzi P. MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol 2013;12:669-676 https://doi.org/10.1016/S1474-4422(13)70103-0
- Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;55:458-468 https://doi.org/10.1002/ana.20016
- Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 2016;12:714-722 https://doi.org/10.1038/nrneurol.2016.166
- Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G, et al. Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol 2018;83:283-294 https://doi.org/10.1002/ana.25146
- Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler 2016;22:1289-1296 https://doi.org/10.1177/1352458515616700
- Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 2019;76:1446-1456 https://doi.org/10.1001/jamaneurol.2019.2478
- Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, De Angelis F, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurology 2018;90:e1183-e1190 https://doi.org/10.1212/WNL.0000000000005256
- Cortese R, Prados Carrasco F, Tur C, Bianchi A, Brownlee W, De Angelis F, et al. Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging. Neurology 2023;100:e308-e323 https://doi.org/10.1212/WNL.0000000000201465
- Solomon AJ, Watts R, Ontaneda D, Absinta M, Sati P, Reich DS. Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm. Mult Scler 2018;24:750-757 https://doi.org/10.1177/1352458517726383
- Kister I, Herbert J, Zhou Y, Ge Y. Ultrahigh-field MR (7T) imaging of brain lesions in neuromyelitis optica. Mult Scler Int 2013;2013:398259
- Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006;63:964-968 https://doi.org/10.1001/archneur.63.7.964
- Cacciaguerra L, Storelli L, Pagani E, Martinelli V, Moiola L, Filippi M, et al. Spatial association between gene expression and brain damage in neuromyelitis optica spectrum disorders (S50.004). Neurology 2023;100(17 Supplement 2):2190
- Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004;127(Pt 1):111-119 https://doi.org/10.1093/brain/awh007
- Werring DJ, Brassat D, Droogan AG, Clark CA, Symms MR, Barker GJ, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000;123(Pt 8):1667-1676 https://doi.org/10.1093/brain/123.8.1667
- Rocca MA, Cercignani M, Iannucci G, Comi G, Filippi M. Weekly diffusion-weighted imaging of normal-appearing white matter in MS. Neurology 2000;55:882-884 https://doi.org/10.1212/WNL.55.6.882
- Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814 https://doi.org/10.1002/ana.410430616
- Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998;43:56-71 https://doi.org/10.1002/ana.410430112
- Tartaglia MC, Narayanan S, De Stefano N, Arnaoutelis R, Antel SB, Francis SJ, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002;249:1382-1390 https://doi.org/10.1007/s00415-002-0846-6
- Filippi M, Agosta F. Magnetization transfer MRI in multiple sclerosis. J Neuroimaging 2007;17(Suppl 1):22S-26S https://doi.org/10.1111/j.1552-6569.2007.00132.x
- Davie CA, Hawkins CP, Barker GJ, Brennan A, Tofts PS, Miller DH, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117(Pt 1):49-58 https://doi.org/10.1093/brain/117.1.49
- De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 1995;38:901-909 https://doi.org/10.1002/ana.410380610
- Naismith RT, Xu J, Tutlam NT, Scully PT, Trinkaus K, Snyder AZ, et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010;74:1694-1701 https://doi.org/10.1212/WNL.0b013e3181e042c4
- Rovira A, Pericot I, Alonso J, Rio J, Grive E, Montalban X. Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. AJNR Am J Neuroradiol 2002;23:989-994
- Fox RJ, Cronin T, Lin J, Wang X, Sakaie K, Ontaneda D, et al. Measuring myelin repair and axonal loss with diffusion tensor imaging. AJNR Am J Neuroradiol 2011;32:85-91 https://doi.org/10.3174/ajnr.A2238
- Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285 https://doi.org/10.1056/NEJM199801293380502
- Chen JT, Collins DL, Atkins HL, Freedman MS, Arnold DL; Canadian MS/BMT Study Group. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008;63:254-262 https://doi.org/10.1002/ana.21302
- Sechi E, Krecke KN, Messina SA, Buciuc M, Pittock SJ, Chen JJ, et al. Comparison of MRI lesion evolution in different central nervous system demyelinating disorders. Neurology 2021;97:e1097-e1109 https://doi.org/10.1212/WNL.0000000000012467
- Schneider T, Brownlee W, Zhang H, Ciccarelli O, Miller DH, Wheeler-Kingshott CG. Sensitivity of multi-shell NODDI to multiple sclerosis white matter changes: a pilot study. Funct Neurol 2017;32:97-101 https://doi.org/10.11138/FNeur/2017.32.2.097
- Rahmanzadeh R, Lu PJ, Barakovic M, Weigel M, Maggi P, Nguyen TD, et al. Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging. Brain 2021;144:1684-1696 https://doi.org/10.1093/brain/awab088
- Kato S, Hagiwara A, Yokoyama K, Andica C, Tomizawa Y, Hoshino Y, et al. Microstructural white matter abnormalities in multiple sclerosis and neuromyelitis optica spectrum disorders: evaluation by advanced diffusion imaging. J Neurol Sci 2022;436:120205
- Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 2015;78:710-721 https://doi.org/10.1002/ana.24497
- Absinta M, Sati P, Schindler M, Leibovitch EC, Ohayon J, Wu T, et al. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest 2016;126:2597-2609 https://doi.org/10.1172/JCI86198
- Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Hoftberger R, Berger T, et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 2017;133:25-42 https://doi.org/10.1007/s00401-016-1636-z
- Chen W, Gauthier SA, Gupta A, Comunale J, Liu T, Wang S, et al. Quantitative susceptibility mapping of multiple sclerosis lesions at various ages. Radiology 2014;271:183-192 https://doi.org/10.1148/radiol.13130353
- Preziosa P, Pagani E, Meani A, Moiola L, Rodegher M, Filippi M, et al. Slowly expanding lesions predict 9-year multiple sclerosis disease progression. Neurol Neuroimmunol Neuroinflamm 2022;9:e1139
- Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, et al. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Mult Scler 2019;25:1915-1925 https://doi.org/10.1177/1352458518814117
- Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H, et al. Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol 2019;76:1474-1483 https://doi.org/10.1001/jamaneurol.2019.2399
- Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Kornek B, Kasprian G, et al. Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. Brain 2021;144:833-847 https://doi.org/10.1093/brain/awaa436
- Cacciaguerra L, Rocca MA, Storelli L, Radaelli M, Filippi M. Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approach. Mult Scler 2021;27:841-854 https://doi.org/10.1177/1352458520941493
- Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, et al. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Mult Scler 2012;18:1259-1268 https://doi.org/10.1177/1352458512436593
- Chawla S, Kister I, Wuerfel J, Brisset JC, Liu S, Sinnecker T, et al. Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI. AJNR Am J Neuroradiol 2016;37:1223-1230 https://doi.org/10.3174/ajnr.A4729
- Clarke MA, Pareto D, Pessini-Ferreira L, Arrambide G, Alberich M, Crescenzo F, et al. Value of 3T susceptibility-weighted imaging in the diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 2020;41:1001-1008 https://doi.org/10.3174/ajnr.A6547
- Poonawalla AH, Hasan KM, Gupta RK, Ahn CW, Nelson F, Wolinsky JS, et al. Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: initial findings. Radiology 2008;246:880-886 https://doi.org/10.1148/radiol.2463070486
- Calabrese M, Rinaldi F, Seppi D, Favaretto A, Squarcina L, Mattisi I, et al. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. Radiology 2011;261:891-898 https://doi.org/10.1148/radiol.11110195
- Filippi M, Preziosa P, Pagani E, Copetti M, Mesaros S, Colombo B, et al. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis. Mult Scler 2013;19:418-426 https://doi.org/10.1177/1352458512457842
- Yaldizli O, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, et al. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: a magnetisation transfer and diffusion tensor imaging study. Mult Scler 2016;22:150-159 https://doi.org/10.1177/1352458515586085
- Preziosa P, Pagani E, Morelli ME, Copetti M, Martinelli V, Pirro F, et al. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS. Mult Scler 2017;23:1918-1928 https://doi.org/10.1177/1352458516689147
- Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ. The substrate of increased cortical FA in MS: a 7T post-mortem MRI and histopathology study. Mult Scler 2016;22:1804-1811 https://doi.org/10.1177/1352458516635290
- Preziosa P, Kiljan S, Steenwijk MD, Meani A, van de Berg WDJ, Schenk GJ, et al. Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex. Brain 2019;142:1921-1937 https://doi.org/10.1093/brain/awz143
- Preziosa P, Pagani E, Bonacchi R, Cacciaguerra L, Falini A, Rocca MA, et al. In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI. J Neurol Neurosurg Psychiatry 2022;93:628-636 https://doi.org/10.1136/jnnp-2021-327803
- Fukutomi H, Glasser MF, Zhang H, Autio JA, Coalson TS, Okada T, et al. Neurite imaging reveals microstructural variations in human cerebral cortical gray matter. Neuroimage 2018;182:488-499 https://doi.org/10.1016/j.neuroimage.2018.02.017
- Grussu F, Schneider T, Tur C, Yates RL, Tachrount M, Ianus, A, et al. Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology? Ann Clin Transl Neurol 2017;4:663-679 https://doi.org/10.1002/acn3.445
- Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304-311 https://doi.org/10.1212/WNL.56.3.304
- Preziosa P, Rocca MA, Mesaros S, Pagani E, Stosic-Opincal T, Kacar K, et al. Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. Radiology 2011;260:541-550 https://doi.org/10.1148/radiol.11110315
- Rocca MA, Absinta M, Amato MP, Moiola L, Ghezzi A, Veggiotti P, et al. Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. Neurology 2014;82:1314-1321 https://doi.org/10.1212/WNL.0000000000000309
- Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CA, Miller DH, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging--evidence of Wallerian degeneration. J Neurol 2003;250:287-292 https://doi.org/10.1007/s00415-003-0992-5
- Mariano R, Messina S, Roca-Fernandez A, Leite MI, Kong Y, Palace JA. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis. Brain 2021;144:198-212 https://doi.org/10.1093/brain/awaa347
- Preziosa P, Pagani E, Meani A, Marchesi O, Conti L, Falini A, et al. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis. J Neurol 2023;270:810-823
- Liu Y, Duan Y, He Y, Yu C, Wang J, Huang J, et al. A tract-based diffusion study of cerebral white matter in neuromyelitis optica reveals widespread pathological alterations. Mult Scler 2012;18:1013-1021 https://doi.org/10.1177/1352458511431731
- Pichiecchio A, Tavazzi E, Poloni G, Ponzio M, Palesi F, Pasin M, et al. Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach. Mult Scler 2012;18:817-824 https://doi.org/10.1177/1352458511431072
- Aboul-Enein F, Krssak M, Hoftberger R, Prayer D, Kristoferitsch W. Diffuse white matter damage is absent in neuromyelitis optica. AJNR Am J Neuroradiol 2010;31:76-79 https://doi.org/10.3174/ajnr.A1791
- Brown JW, Pardini M, Brownlee WJ, Fernando K, Samson RS, Prados Carrasco F, et al. An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis. Brain 2017;140:387-398 https://doi.org/10.1093/brain/aww296
- Pirpamer L, Kincses B, Kincses ZT, Kiss C, Damulina A, Khalil M, et al. Periventricular magnetisation transfer abnormalities in early multiple sclerosis. Neuroimage Clin 2022;34:103012
- Liu Z, Pardini M, Yaldizli O, Sethi V, Muhlert N, Wheeler-Kingshott CA, et al. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Brain 2015;138(Pt 5):1239-1246 https://doi.org/10.1093/brain/awv065
- Pardini M, Gualco L, Bommarito G, Roccatagliata L, Schiavi S, Solaro C, et al. CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS. Mult Scler Relat Disord 2019;31:93-96 https://doi.org/10.1016/j.msard.2019.03.027
- De Meo E, Storelli L, Moiola L, Ghezzi A, Veggiotti P, Filippi M, et al. In vivo gradients of thalamic damage in paediatric multiple sclerosis: a window into pathology. Brain 2021;144:186-197 https://doi.org/10.1093/brain/awaa379
- Fadda G, Brown RA, Magliozzi R, Aubert-Broche B, O'Mahony J, Shinohara RT, et al. A surface-in gradient of thalamic damage evolves in pediatric multiple sclerosis. Ann Neurol 2019;85:340-351 https://doi.org/10.1002/ana.25429
- Mainero C, Louapre C, Govindarajan ST, Gianni C, Nielsen AS, Cohen-Adad J, et al. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain 2015;138:932-945 https://doi.org/10.1093/brain/awv011
- Pardini M, Brown JWL, Magliozzi R, Reynolds R, Chard DT. Surface-in pathology in multiple sclerosis: a new view on pathogenesis? Brain 2021;144:1646-1654 https://doi.org/10.1093/brain/awab025
- Guo Y, Lennon VA, Parisi JE, Popescu B, Vasquez C, Pittock SJ, et al. Spectrum of sublytic astrocytopathy in neuromyelitis optica. Brain 2022;145:1379-1390 https://doi.org/10.1093/brain/awab394
- Solar P, Zamani A, Kubickova L, Dubovy P, Joukal M. Choroid plexus and the blood-cerebrospinal fluid barrier in disease. Fluids Barriers CNS 2020;17:35
- Ghersi-Egea JF, Strazielle N, Catala M, Silva-Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease. Acta Neuropathol 2018;135:337-361 https://doi.org/10.1007/s00401-018-1807-1
- Margoni M, Gueye M, Meani A, Pagani E, Moiola L, Preziosa P, et al. Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex. J Neurol Neurosurg Psychiatry 2023;94:181-188 https://doi.org/10.1136/jnnp-2022-330343
- Bergsland N, Dwyer MG, Jakimovski D, Tavazzi E, Benedict RHB, Weinstock-Guttman B, et al. Association of choroid plexus inflammation on MRI with clinical disability progression over 5 years in patients with multiple sclerosis. Neurology 2023;100:e911-e920 https://doi.org/10.1212/WNL.0000000000201608
- Fleischer V, Gonzalez-Escamilla G, Ciolac D, Albrecht P, Kury P, Gruchot J, et al. Translational value of choroid plexus imaging for tracking neuroinflammation in mice and humans. Proc Natl Acad Sci U S A 2021;118:e2025000118
- Muller J, Sinnecker T, Wendebourg MJ, Schlager R, Kuhle J, Schadelin S, et al. Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis. Neurol Neuroimmunol Neuroinflamm 2022;9:e1147
- Ricigliano VAG, Morena E, Colombi A, Tonietto M, Hamzaoui M, Poirion E, et al. Choroid plexus enlargement in inflammatory multiple sclerosis: 3.0-T MRI and translocator protein PET evaluation. Radiology 2021;301:166-177 https://doi.org/10.1148/radiol.2021204426
- Klistorner S, Van der Walt A, Barnett MH, Butzkueven H, Kolbe S, Parratt J, et al. Choroid plexus volume is enlarged in clinically isolated syndrome patients with optic neuritis. Mult Scler 2023;29:540-548 https://doi.org/10.1177/13524585231157206
- Klistorner S, Barnett MH, Parratt J, Yiannikas C, Graham SL, Klistorner A. Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy. Ann Clin Transl Neurol 2022;9:1528-1537 https://doi.org/10.1002/acn3.51644
- Tonietto M, Poirion E, Lazzarotto A, Ricigliano V, Papeix C, Bottlaender M, et al. Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration. Brain 2023;146:182-194 https://doi.org/10.1093/brain/awac334
- Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol 2018;17:1016-1024 https://doi.org/10.1016/S1474-4422(18)30318-1
- Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, et al. Dynamic 11C-PiB PET shows cerebrospinal fluid flow alterations in Alzheimer disease and multiple sclerosis. J Nucl Med 2019;60:1452-1460 https://doi.org/10.2967/jnumed.118.223834
- Carotenuto A, Cacciaguerra L, Pagani E, Preziosa P, Filippi M, Rocca MA. Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability. Brain 2022;145:2785-2795 https://doi.org/10.1093/brain/awab454
- Taoka T, Masutani Y, Kawai H, Nakane T, Matsuoka K, Yasuno F, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases. Jpn J Radiol 2017;35:172-178 https://doi.org/10.1007/s11604-017-0617-z
- Cacciaguerra L, Carotenuto A, Pagani E, Mistri D, Radaelli M, Martinelli V, et al. Magnetic resonance imaging evaluation of perivascular space abnormalities in neuromyelitis optica. Ann Neurol 2022;92:173-183 https://doi.org/10.1002/ana.26419
- Iliff JJ, Nedergaard M. Is there a cerebral lymphatic system? Stroke 2013;44(6 Suppl 1):S93-S95 https://doi.org/10.1161/STROKEAHA.112.678698
- Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner's guide. Neurochem Res 2015;40:2583-2599 https://doi.org/10.1007/s11064-015-1581-6
- Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125(Pt 7):1450-1461 https://doi.org/10.1093/brain/awf151
- Taoka T, Ito R, Nakamichi R, Nakane T, Kawai H, Naganawa S. Interstitial fluidopathy of the central nervous system: an umbrella term for disorders with impaired neurofluid dynamics. Magn Reson Med Sci 2022 Nov 25. [Epub]. https://doi.org/10.2463/mrms.rev.2022-0012
- Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol 2015;7:a020412
- Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793 https://doi.org/10.1002/ana.410420515
- Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, et al. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995;45:1122-1126 https://doi.org/10.1212/WNL.45.6.1122
- Gaitan MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011;70:22-29 https://doi.org/10.1002/ana.22472
- Cotton F, Weiner HL, Jolesz FA, Guttmann CR. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 2003;60:640-646 https://doi.org/10.1212/01.WNL.0000046587.83503.1E
- Cramer SP, Modvig S, Simonsen HJ, Frederiksen JL, Larsson HB. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain 2015;138(Pt 9):2571-2583 https://doi.org/10.1093/brain/awv203
- Varatharaj A, Darekar A, Gawne-Cain M, Cramer SP, Larsson HB, Galea I. 009 Abnormal blood-brain barrier permeability in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2022;93:A16
- Davis M, Auh S, Riva M, Richert ND, Frank JA, McFarland HF, et al. Ring and nodular multiple sclerosis lesions: a retrospective natural history study. Neurology 2010;74:851-856 https://doi.org/10.1212/WNL.0b013e3181d31df5
- Gaitan MI, Sati P, Inati SJ, Reich DS. Initial investigation of the blood-brain barrier in MS lesions at 7 tesla. Mult Scler 2013;19:1068-1073 https://doi.org/10.1177/1352458512471093
- Absinta M, Sati P, Gaitan MI, Maggi P, Cortese IC, Filippi M, et al. Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol 2013;74:669-678 https://doi.org/10.1002/ana.23959
- Saadoun S, Papadopoulos MC. Aquaporin-4 in brain and spinal cord oedema. Neuroscience 2010;168:1036-1046 https://doi.org/10.1016/j.neuroscience.2009.08.019
- Shimizu F, Sano Y, Takahashi T, Haruki H, Saito K, Koga M, et al. Sera from neuromyelitis optica patients disrupt the blood-brain barrier. J Neurol Neurosurg Psychiatry 2012;83:288-297 https://doi.org/10.1136/jnnp-2011-300434
- Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009;66:425-428 https://doi.org/10.1002/ana.21753
- Shah SS, Morris P, Buciuc M, Tajfirouz D, Wingerchuk DM, Weinshenker BG, et al. Frequency of asymptomatic optic nerve enhancement in a large retrospective cohort of patients with aquaporin-4+ NMOSD. Neurology 2022;99:e851-e857 https://doi.org/10.1212/WNL.0000000000200838
- Magana SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, Rabinstein AA, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009;72:712-717 https://doi.org/10.1212/01.wnl.0000343001.36493.ae
- Hyun JW, Kim SH, Jeong IH, Lee SH, Kim HJ. Bright spotty lesions on the spinal cord: an additional MRI indicator of neuromyelitis optica spectrum disorder? J Neurol Neurosurg Psychiatry 2015;86:1280-1282 https://doi.org/10.1136/jnnp-2014-309761
- Hyun JW, Lee HL, Park J, Kim J, Min JH, Kim BJ, et al. Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD. Mult Scler 2022;28:989-992 https://doi.org/10.1177/13524585211060326
- Bonnier G, Roche A, Romascano D, Simioni S, Meskaldji D, Rotzinger D, et al. Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis. Ann Clin Transl Neurol 2014;1:423-432 https://doi.org/10.1002/acn3.68
- Cacciaguerra L, Pagani E, Radaelli M, Mesaros S, Martinelli V, Ivanovic J, et al. MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD. J Neurol Neurosurg Psychiatry 2022;93:753-760 https://doi.org/10.1136/jnnp-2022-328956
- Aktas O, Smith MA, Rees WA, Bennett JL, She D, Katz E, et al. Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker. Ann Neurol 2021;89:895-910 https://doi.org/10.1002/ana.26067
- Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188-2197 https://doi.org/10.1056/NEJMoa1100648
- Absinta M, Cortese IC, Vuolo L, Nair G, de Alwis MP, Ohayon J, et al. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology 2017;88:1439-1444 https://doi.org/10.1212/WNL.0000000000003820
- Ineichen BV, Tsagkas C, Absinta M, Reich DS. Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: a systematic review and meta-analysis. Neuroimage Clin 2022;33:102939
- Harrison DM, Wang KY, Fiol J, Naunton K, Royal W 3rd, Hua J, et al. Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume. J Neuroimaging 2017;27:461-468 https://doi.org/10.1111/jon.12444
- Absinta M, Vuolo L, Rao A, Nair G, Sati P, Cortese IC, et al. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 2015;85:18-28 https://doi.org/10.1212/WNL.0000000000001587
- Mainero C, Louapre C. Meningeal inflammation in multiple sclerosis: the key to the origin of cortical lesions? Neurology 2015;85:12-13 https://doi.org/10.1212/WNL.0000000000001586
- Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, et al. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. Mult Scler Relat Disord 2021;47:102653
- Bhargava P, Wicken C, Smith MD, Strowd RE, Cortese I, Reich DS, et al. Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement. Mult Scler Relat Disord 2019;30:136-140 https://doi.org/10.1016/j.msard.2019.02.013
- Jonas SN, Izbudak I, Frazier AA, Harrison DM. Longitudinal persistence of meningeal enhancement on postcontrast 7T 3D-FLAIR MRI in multiple sclerosis. AJNR Am J Neuroradiol 2018;39:1799-1805 https://doi.org/10.3174/ajnr.A5796
- Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, et al. Effect of teriflunomide and dimethyl fumarate on cortical atrophy and leptomeningeal inflammation in multiple sclerosis: a retrospective, observational, case-control pilot study. J Clin Med 2019;8:344
- Makshakov G, Magonov E, Totolyan N, Nazarov V, Lapin S, Mazing A, et al. Leptomeningeal contrast enhancement is associated with disability progression and grey matter atrophy in multiple sclerosis. Neurol Res Int 2017;2017:8652463
- Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, et al. Evaluation of leptomeningeal contrast enhancement using pre-and postcontrast subtraction 3D-FLAIR imaging in multiple sclerosis. AJNR Am J Neuroradiol 2018;39:642-647 https://doi.org/10.3174/ajnr.A5541
- Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B, Zivadinov R. Leptomeningeal contrast enhancement is related to focal cortical thinning in relapsing-remitting multiple sclerosis: a cross-sectional MRI study. AJNR Am J Neuroradiol 2019;40:620-625 https://doi.org/10.3174/ajnr.A6011
- Ighani M, Jonas S, Izbudak I, Choi S, Lema-Dopico A, Hua J, et al. No association between cortical lesions and leptomeningeal enhancement on 7-tesla MRI in multiple sclerosis. Mult Scler 2020;26:165-176 https://doi.org/10.1177/1352458519876037
- Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, et al. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: a retrospective, pilot, observational longitudinal study. Mult Scler 2017;23:1336-1345 https://doi.org/10.1177/1352458516678083
- Zurawski J, Tauhid S, Chu R, Khalid F, Healy BC, Weiner HL, et al. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult Scler 2020;26:177-187 https://doi.org/10.1177/1352458519885106
- Absinta M, Ontaneda D. Controversial association between leptomeningeal enhancement and demyelinated cortical lesions in multiple sclerosis. Mult Scler 2020;26:135-136 https://doi.org/10.1177/1352458519892186
- Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, et al. Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm 2017;4:e343
- Fan Y, Shan F, Lin SP, Long Y, Liang B, Gao C, et al. Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica. Int J Neurosci 2016;126:448-454 https://doi.org/10.3109/00207454.2015.1055356
- Long Y, Chen M, Zhang B, Gao C, Zheng Y, Xie L, et al. Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. J Neuroimmunol 2014;269:62-67 https://doi.org/10.1016/j.jneuroim.2014.02.006
- Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994;51:874-887 https://doi.org/10.1001/archneur.1994.00540210046012
- Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158-170 https://doi.org/10.1016/S1474-4422(06)70349-0
- Grassiot B, Desgranges B, Eustache F, Defer G. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol 2009;256:1397-1412 https://doi.org/10.1007/s00415-009-5108-4
- De Stefano N, Stromillo ML, Giorgio A, Bartolozzi ML, Battaglini M, Baldini M, et al. Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:93-99 https://doi.org/10.1136/jnnp-2014-309903
- Cole JH, Raffel J, Friede T, Eshaghi A, Brownlee WJ, Chard D, et al. Longitudinal assessment of multiple sclerosis with the brain-age paradigm. Ann Neurol 2020;88:93-105 https://doi.org/10.1002/ana.25746
- Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008;64:255-265 https://doi.org/10.1002/ana.21436
- Filippi M, Preziosa P, Copetti M, Riccitelli G, Horsfield MA, Martinelli V, et al. Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology 2013;81:1759-1767 https://doi.org/10.1212/01.wnl.0000435551.90824.d0
- Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131(Pt 4):1134-1141 https://doi.org/10.1093/brain/awn030
- Rocca MA, Longoni G, Pagani E, Boffa G, Colombo B, Rodegher M, et al. In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis. Hum Brain Mapp 2015;36:4702-4713 https://doi.org/10.1002/hbm.22946
- Cacciaguerra L, Pagani E, Mesaros S, Dackovic J, Dujmovic-Basuroski I, Drulovic J, et al. Dynamic volumetric changes of hippocampal subfields in clinically isolated syndrome patients: a 2-year MRI study. Mult Scler 2019;25:1232-1242 https://doi.org/10.1177/1352458518787347
- Planche V, Koubiyr I, Romero JE, Manjon JV, Coupe P, Deloire M, et al. Regional hippocampal vulnerability in early multiple sclerosis: dynamic pathological spreading from dentate gyrus to CA1. Hum Brain Mapp 2018;39:1814-1824 https://doi.org/10.1002/hbm.23970
- Longoni G, Rocca MA, Pagani E, Riccitelli GC, Colombo B, Rodegher M, et al. Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS. Brain Struct Funct 2015;220:435-444 https://doi.org/10.1007/s00429-013-0665-9
- Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-1223 https://doi.org/10.1212/01.wnl.0000276992.17011.b5
- Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, et al. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 2008;70(13 Pt 2):1107-1112 https://doi.org/10.1212/01.wnl.0000291010.54692.85
- Aubert-Broche B, Fonov V, Ghassemi R, Narayanan S, Arnold DL, Banwell B, et al. Regional brain atrophy in children with multiple sclerosis. Neuroimage 2011;58:409-415 https://doi.org/10.1016/j.neuroimage.2011.03.025
- Mesaros S, Rocca MA, Pagani E, Sormani MP, Petrolini M, Comi G, et al. Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years. AJNR Am J Neuroradiol 2011;32:1016-1020 https://doi.org/10.3174/ajnr.A2430
- Rocca MA, Mesaros S, Pagani E, Sormani MP, Comi G, Filippi M. Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology 2010;257:463-469 https://doi.org/10.1148/radiol.10100326
- Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, et al. Investigating grey matter atrophy and its relationship with white matter lesions in MS, MOGAD and AQP4-NMOSD. Mult Scler J 2022;28(Suppl 3):27-29
- Rocca MA, Preziosa P, Mesaros S, Pagani E, Dackovic J, Stosic-Opincal T, et al. Clinically isolated syndrome suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes-a 2-year MR imaging study. Radiology 2016;278:841-853 https://doi.org/10.1148/radiol.2015150532
- Moccia M, Prados F, Filippi M, Rocca MA, Valsasina P, Brownlee WJ, et al. Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral. Ann Neurol 2019;86:704-713 https://doi.org/10.1002/ana.25571
- Rocca MA, Valsasina P, Meani A, Gobbi C, Zecca C, Rovira A, et al. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS. Neurology 2019;93:e1852-e1866 https://doi.org/10.1212/WNL.0000000000008466
- Valsasina P, Aboulwafa M, Preziosa P, Messina R, Falini A, Comi G, et al. Cervical cord T1-weighted hypointense lesions at MR imaging in multiple sclerosis: relationship to cord atrophy and disability. Radiology 2018;288:234-244 https://doi.org/10.1148/radiol.2018172311
- Bonacchi R, Pagani E, Meani A, Cacciaguerra L, Preziosa P, De Meo E, et al. Clinical relevance of multiparametric MRI assessment of cervical cord damage in multiple sclerosis. Radiology 2020;296:605-615 https://doi.org/10.1148/radiol.2020200430
- Havrdova E, Arnold DL, Cohen JA, Hartung HP, Fox EJ, Giovannoni G, et al. Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy. Neurology 2017;89:1107-1116 https://doi.org/10.1212/WNL.0000000000004313
- De Stefano N, Giorgio A, Battaglini M, De Leucio A, Hicking C, Dangond F, et al. Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. Mult Scler 2018;24:222-226 https://doi.org/10.1177/1352458517690269
- Lee H, Narayanan S, Brown RA, Chen JT, Atkins HL, Freedman MS, et al. Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis. Mult Scler 2017;23:420-431 https://doi.org/10.1177/1352458516650992
- Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, et al. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol 2020;16:171-182 https://doi.org/10.1038/s41582-020-0314-x
- Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Muto M, et al. Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry 2022;93:32-40 https://doi.org/10.1136/jnnp-2021-326386
- Chanson JB, Lamy J, Rousseau F, Blanc F, Collongues N, Fleury M, et al. White matter volume is decreased in the brain of patients with neuromyelitis optica. Eur J Neurol 2013;20:361-367 https://doi.org/10.1111/j.1468-1331.2012.03867.x
- Duan Y, Liu Y, Liang P, Jia X, Ye J, Dong H, et al. White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study. Acta Radiol 2014;55:589-593 https://doi.org/10.1177/0284185113501815
- Blanc F, Noblet V, Jung B, Rousseau F, Renard F, Bourre B, et al. White matter atrophy and cognitive dysfunctions in neuromyelitis optica. PLoS One 2012;7:e33878
- Duan Y, Liu Y, Liang P, Jia X, Yu C, Qin W, et al. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. Eur J Radiol 2012;81:e110-e114 https://doi.org/10.1016/j.ejrad.2011.01.065
- Liu Y, Xie T, He Y, Duan Y, Huang J, Ren Z, et al. Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica. Eur Radiol 2014;24:2334-2343 https://doi.org/10.1007/s00330-014-3239-1
- Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L, et al. Structural MRI substrates of cognitive impairment in neuromyelitis optica. Neurology 2015;85:1491-1499 https://doi.org/10.1212/WNL.0000000000002067
- Chien C, Scheel M, Schmitz-Hubsch T, Borisow N, Ruprecht K, Bellmann-Strobl J, et al. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity. Mult Scler 2019;25:1926-1936 https://doi.org/10.1177/1352458518815596
- Cacciaguerra L, Valsasina P, Mesaros S, Martinelli V, Drulovic J, Filippi M, et al. Spinal cord atrophy in neuromyelitis optica spectrum disorders is spatially related to cord lesions and disability. Radiology 2020;297:154-163 https://doi.org/10.1148/radiol.2020192664
- Nakamura K, Chen JT, Ontaneda D, Fox RJ, Trapp BD. T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis. Ann Neurol 2017;82:635-639 https://doi.org/10.1002/ana.25019
- Righart R, Biberacher V, Jonkman LE, Klaver R, Schmidt P, Buck D, et al. Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging. Ann Neurol 2017;82:519-529 https://doi.org/10.1002/ana.25020
- reziosa P, Bouman PM, Kiljan S, Steenwijk MD, Meani A, Pouwels PJ, et al. Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis. J Neurol Neurosurg Psychiatry 2021;92:790-792 https://doi.org/10.1136/jnnp-2020-324391
- Tu TW, Williams RA, Lescher JD, Jikaria N, Turtzo LC, Frank JA. Radiological-pathological correlation of diffusion tensor and magnetization transfer imaging in a closed head traumatic brain injury model. Ann Neurol 2016;79:907-920 https://doi.org/10.1002/ana.24641
- Basser PJ, Mattiello J, LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247-254 https://doi.org/10.1006/jmrb.1994.1037
- Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 2012;61:1000-1016 https://doi.org/10.1016/j.neuroimage.2012.03.072